Understanding brain connectivity and genetic factors in neuropsychiatric disorders

Mapping functional brain connectivity, neurodevelopment, and imaging-genetic associations in individuals with genetic and clinical risk factors for neuropsychiatric illness

NIH-funded research University of California Los Angeles · NIH-10898593

This study is looking at how genes and the environment influence brain development in people with 22q11.2 Deletion Syndrome, especially those at risk for mental health issues, by using special brain scans to see how their brains connect compared to those of people without this condition.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles NIH-funded
Lab location1 site (Los Angeles, United States)
Project IDNIH-10898593 on NIH RePORTER

What this research studies

This research investigates how genetic and environmental factors affect brain development and function in individuals with neurodevelopmental disorders, particularly focusing on those with 22q11.2 Deletion Syndrome. By using advanced imaging techniques like resting-state fMRI, the study aims to map brain connectivity patterns in individuals at risk for psychosis and compare them to typically developing individuals. The research will analyze a large dataset from multiple sites to identify biological pathways that contribute to conditions such as schizophrenia, autism, and anxiety disorders.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with 22q11.2 Deletion Syndrome and those at clinical high risk for developing psychosis.

Not a fit: Patients without genetic or clinical risk factors for neuropsychiatric illnesses may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for individuals with neurodevelopmental disorders.

How similar studies have performed: Previous research has shown promising results in understanding neurodevelopmental disorders through genetic studies, making this approach both relevant and potentially impactful.

Where this research is happening

Los Angeles, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions 22q11 Chromosomal Microdeletion Syndrome22q11 Deletion Syndrome22q11.2 deletion syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.